QURE Stock Rockets After FDA Approves Its Most Expensive Drug Ever
The Food and Drug Administration just approved its most expensive drug ever — a hemophilia gene therapy from Carlisle Companies (CSL) and UniQure (QURE) — and QURE stock popped Wednesday. X The infusion is approved for hemophilia B patients currently on a prevention regimen called Factor IX therapy, or who have a history of potentially … Read more